CHG-2023-0254

Manufacturing Process Change for Glucovantib. Facility Change for Glucovantib — routine update. Impacts 5 markets and 5 variations.

Change Number
CHG-2023-0254
Type
Manufacturing Process Change
Product
Glucovantib
Status
Blocked
Owner
Carlos Mendez
Initiated
2022-02-02
Description

Facility Change for Glucovantib — routine update

Impacted Markets (5)
TW — TaiwanMX — MexicoSA — Saudi ArabiaPT — PortugalDK — Denmark
Impacted Modules
3.2.P3.2.P.33.2.S4.2.1
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved